Registered trials address questions already answered with high-certainty evidence: A sample of current redundant

Laura Vergara-Merino1, Catalina Verdejo2, Juan Victor Ariel Franco3

  • 1Cochrane Chile, Associate Centre Universidad de Valparaíso, Angamos 655, room 1111, Viña del Mar, Chile; Interdisciplinary Centre for Health Studies CIESAL, Universidad de Valparaíso, Chile; School of Medicine, Universidad de Valparaíso, Angamos 655, Viña del Mar, Chile.

Abstract

Insights

Researchers found 39 clinical trials registered after 2015 that study primary outcomes with high certainty of evidence (CoE) already established in Cochrane reviews. This highlights ongoing research in areas with strong existing evidence.

Area of Science:

  • Evidence-based medicine
  • Systematic reviews
  • Clinical trial registration

Background:

  • Cochrane Systematic Reviews (SRs) are crucial for synthesizing research evidence.
  • The GRADE system assesses the Certainty of Evidence (CoE) for primary outcomes.
  • Identifying research gaps and redundancies is vital for efficient healthcare resource allocation.

Purpose of the Study:

  • To identify clinical trials registered after 2015.
  • To focus on primary outcomes with a pre-existing "high" Certainty of Evidence (CoE) rating from Cochrane SRs.

Main Methods:

  • Searched Cochrane Library for SRs published in 2015.
  • Extracted GRADE CoE ratings for primary outcomes from Summary of Findings (SoF) tables.
  • Searched clinical trial registries (WHO ICTRP, ClinicalTrials.gov) for studies registered post-SR publication.

Main Results:

  • Analyzed 602 SRs, identifying 81 with at least one primary outcome rated "high" CoE (totaling 152 outcomes).
  • Discovered 39 clinical trials registered for these high CoE primary outcomes.
  • Found ongoing clinical trial registration for outcomes with established high-certainty evidence.

Conclusions:

  • This study confirms the registration of clinical trials for primary outcomes where high-certainty evidence already exists.
  • Suggests potential for research duplication or the need for further investigation into the rationale for such trials.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.0K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.2K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
264
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
376
Testing a Claim about Population Proportion01:24

Testing a Claim about Population Proportion

A complete procedure for testing a claim about a population proportion is provided here.
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...
3.6K
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
72